US · OMDA
Omada Health
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- San Francisco, CA 94080
- Website
- omadahealth.com
Price · as of 2026-09-03
$22.29
Market cap 1.41B
Price history
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | $37.90 | +70% |
| P/E | -66.44 | |
| P/B | 3.70 | |
| P/S | 3.26 | |
| EV/EBITDA | -131.90 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | |||||
| 2025 | $14.53 | $37.90 |
Line items
Line items
Line items
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Growth | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| OMDA | Omada Health | $23.67 | 1.41B | $37.90 | +60% | -66.44 | 3.70 | 3.26 | -131.90 | 53.24% |
| BCRX | BioCryst Pharmaceuticals,… | $9.38 | 2.38B | $71.19 | +659% | 6.54 | -14.48 | 1.97 | 5.43 | 94.10% |
| MAZE | Maze Therapeutics, Inc. | $28.65 | 1.59B | — | — | -16.46 | 6.08 | — | -14.29 | -100.00% |
| OMCL | Omnicell, Inc. | $36.81 | 1.67B | $40.53 | +10% | 770.56 | 1.28 | 1.33 | 15.45 | 6.53% |
| PGNY | Progyny, Inc. | $28.10 | 2.2B | $31.75 | +13% | 25.49 | 2.89 | 1.16 | 12.05 | 10.40% |
| PHR | Phreesia, Inc. | $12.51 | 773.27M | $30.12 | +141% | 208.80 | 1.43 | 1.00 | 17.31 | 14.48% |
| SDGR | Schrödinger, Inc. | $18.16 | 1.36B | $27.33 | +50% | -8.90 | 2.52 | 3.59 | -6.57 | 23.29% |
| TDOC | Teladoc Health, Inc. | $7.13 | 1.3B | $21.18 | +197% | -4.72 | 0.68 | 0.37 | 8.18 | -1.54% |
| TXG | 10x Genomics, Inc. | $52.03 | 6.61B | $32.72 | -37% | -53.83 | 2.94 | 3.65 | 506.11 | 5.25% |
| UFPT | UFP Technologies, Inc. | $314.01 | 2.43B | $181.28 | -42% | 22.99 | 3.71 | 2.61 | 14.73 | 19.50% |
| XERS | Xeris Biopharma Holdings,… | $7.93 | 1.37B | $29.58 | +273% | 1581.09 | 63.99 | 3.00 | 63.15 | 43.72% |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($37.90 ÷ $22.29) − 1 = +70.04% (IC, example).